As an illustration, it's been demonstrated that prime-dose CsA—but not lower dose CsA—immediately inhibits the expression of NFATc1 and IL-two in human T cells from stimulated complete blood samples, assessed by flow cytometry (23). Hence, in contrast to other cytotoxic immune suppressors, CsA would not destroy the immune effector cells https://michaelc332ozk5.blogdemls.com/profile